Biotech ETFs Pop Amid Pending J&J Vaccine Approval

HomeETFs

Biotech ETFs Pop Amid Pending J&J Vaccine Approval

Biotech ETFs are climbing Wednesday because the Meals and Drug Administration’s workers endorsed Johnson & Johnson’s coronavirus vaccine for em



Biotech ETFs are climbing Wednesday because the Meals and Drug Administration’s workers endorsed Johnson & Johnson’s coronavirus vaccine for emergency use, a key step in providing a 3rd vaccination to the U.S. market. The workers report launched Wednesday is a preliminary step designed to organize the FDA’s Vaccines and Associated Organic Merchandise Advisory Committee to make […] Learn extra at ETFtrends.com.



www.nasdaq.com